HK1143207A1 - An assay to detect a gynecological cancer - Google Patents

An assay to detect a gynecological cancer

Info

Publication number
HK1143207A1
HK1143207A1 HK10109766.1A HK10109766A HK1143207A1 HK 1143207 A1 HK1143207 A1 HK 1143207A1 HK 10109766 A HK10109766 A HK 10109766A HK 1143207 A1 HK1143207 A1 HK 1143207A1
Authority
HK
Hong Kong
Prior art keywords
assay
detect
gynecological cancer
gynecological
cancer
Prior art date
Application number
HK10109766.1A
Other languages
English (en)
Inventor
Dominic J Autelitano
Tracey A Edgell
Nick Gatsios
Leodevico L Ilag
Original Assignee
Healthlinx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008902029A external-priority patent/AU2008902029A0/en
Application filed by Healthlinx Ltd filed Critical Healthlinx Ltd
Publication of HK1143207A1 publication Critical patent/HK1143207A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
HK10109766.1A 2008-04-23 2010-10-15 An assay to detect a gynecological cancer HK1143207A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008902029A AU2008902029A0 (en) 2008-04-23 An assay to detect a gynecological condition
AU2008905120A AU2008905120A0 (en) 2008-10-01 An assay to detect a gynecological condition
PCT/AU2009/000500 WO2009129569A1 (en) 2008-04-23 2009-04-21 An assay to detect a gynecological condition

Publications (1)

Publication Number Publication Date
HK1143207A1 true HK1143207A1 (en) 2010-12-24

Family

ID=41216335

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10109766.1A HK1143207A1 (en) 2008-04-23 2010-10-15 An assay to detect a gynecological cancer

Country Status (14)

Country Link
US (2) US20110033377A1 (xx)
EP (1) EP2281200A4 (xx)
KR (1) KR101300694B1 (xx)
CN (1) CN102066939A (xx)
AU (1) AU2009240781B2 (xx)
BR (1) BRPI0911462A2 (xx)
CA (1) CA2725442A1 (xx)
CO (1) CO6311041A2 (xx)
GB (1) GB2464647B (xx)
HK (1) HK1143207A1 (xx)
IL (1) IL208506A (xx)
NZ (1) NZ588406A (xx)
RU (1) RU2010147643A (xx)
WO (1) WO2009129569A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3546939A3 (en) * 2009-12-23 2019-11-06 Cellestis Limited An assay for measuring cell-mediated immunoresponsiveness
CA2798441A1 (en) * 2010-05-07 2011-11-10 Abbvie Inc. Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
CN103703375B (zh) * 2011-06-29 2018-04-10 塞尔雷斯蒂斯有限公司 具有增强灵敏度的细胞介导免疫应答测定
US20150004633A1 (en) * 2012-02-07 2015-01-01 Quest Diagnostics Investments Incorporated Assays and methods for the diagnosis of ovarian cancer
JP2019515265A (ja) * 2016-04-20 2019-06-06 エーザイ インク． バイオマーカーを使用する漿液性卵巣がんの予後
KR101809149B1 (ko) * 2016-11-25 2017-12-14 한국과학기술연구원 순환계질환 발생잠재도를 판단하는 장치 및 그 방법
US20180173847A1 (en) * 2016-12-16 2018-06-21 Jang-Jih Lu Establishing a machine learning model for cancer anticipation and a method of detecting cancer by using multiple tumor markers in the machine learning model for cancer anticipation
CN108567413A (zh) * 2018-03-02 2018-09-25 黑龙江中医药大学 一种医院妇科用多功能的疾病检查设备及检查系统
CA3127584A1 (en) * 2018-06-14 2019-12-19 Metabolomycs, Inc. Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
AU2021224890A1 (en) * 2020-02-19 2022-09-15 Aspira Women's Health Inc. Compositions for endometriosis assessment having improved specificity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20070042405A1 (en) * 2003-08-15 2007-02-22 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Enhanced diagnostic multimarker serological profiling
US7910318B2 (en) * 2005-09-15 2011-03-22 The Royal Institution For The Advancement Of Learning/Mcgill University Methods of diagnosing ovarian cancer and kits therefor
WO2008003024A2 (en) * 2006-06-28 2008-01-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
SG182976A1 (en) * 2007-06-29 2012-08-30 Ahngook Pharmaceutical Co Ltd Predictive markers for ovarian cancer

Also Published As

Publication number Publication date
EP2281200A4 (en) 2011-07-06
NZ588406A (en) 2012-05-25
GB2464647A (en) 2010-04-28
US20150025810A1 (en) 2015-01-22
EP2281200A1 (en) 2011-02-09
IL208506A (en) 2013-08-29
CO6311041A2 (es) 2011-08-22
IL208506A0 (en) 2010-12-30
CN102066939A (zh) 2011-05-18
KR101300694B1 (ko) 2013-08-26
CA2725442A1 (en) 2009-10-29
AU2009240781B2 (en) 2011-02-17
GB2464647B (en) 2011-02-16
RU2010147643A (ru) 2012-05-27
WO2009129569A1 (en) 2009-10-29
GB201002660D0 (en) 2010-04-07
US20110033377A1 (en) 2011-02-10
BRPI0911462A2 (pt) 2015-10-06
KR20100126258A (ko) 2010-12-01
AU2009240781A1 (en) 2009-10-29

Similar Documents

Publication Publication Date Title
GB2464647B (en) An assay to detect a gynecological cancer
GB0921062D0 (en) Phased based sensing
IL207866A0 (en) Proximity sensors
GB0903469D0 (en) Assay
GB0921447D0 (en) Assay
GB0914826D0 (en) Assay methods
GB201001079D0 (en) Prognostic assay
EP2451984A4 (en) DETECTION OF MULTINUCLEOTIDE REPETITIONS
GB0918712D0 (en) An assay
GB0909130D0 (en) Assay device
GB0904639D0 (en) Assay
GB0902565D0 (en) Assay
GB0811567D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB0811858D0 (en) Assay
GB0809262D0 (en) Assay
GB0921873D0 (en) Assay
GB0907516D0 (en) Assay
GB2473067B (en) Proximity sensors
GB0822260D0 (en) Assay
GB0822261D0 (en) Assay
GB0822010D0 (en) Assay
GB0821624D0 (en) Assay
GB0814591D0 (en) Assay